How to Help Your Patients Save Money on Citanest: A Provider's Guide to Savings Programs

The discontinuation of Citanest Plain Dental introduces a new layer of complexity for dental practices: not only do you need to substitute an anesthetic, but you also want to ensure this transition does not adversely affect your patients' out-of-pocket dental costs or create concerns about their treatment. This provider-focused guide covers how dental anesthetic costs flow through the billing system, how to manage the transition efficiently, and how to connect patients with assistance programs when overall dental costs are a barrier.

How Dental Anesthetic Costs Are Structured

Dental local anesthetics are professional supplies absorbed into practice overhead — they are not billed as separate line items to patients in most cases. This means:

• Switching from Citanest to mepivacaine or articaine typically has no direct impact on patient billing
• The anesthetic choice affects your practice's supply costs, not the patient's bill
• Insurance plans reimburse procedures by CDT code (D9930, D9930, etc.) — not by specific anesthetic used

Managing Supply Costs When Transitioning Away From Citanest

From a practice economics standpoint, the switch from Citanest should be cost-neutral or even cost-saving:

• Mepivacaine 3% plain: Widely available, competitive pricing from multiple distributors. Approximately $40-$60 per box of 50 cartridges from major distributors.
• Articaine 4% (Septocaine): Similarly priced to mepivacaine and available from all major distributors. Volume purchasing contracts with your distributor can further reduce per-cartridge cost.
• Avoid premium pricing for Citanest Forte: If Citanest Forte is still available and you choose to stock it, be aware that limited supply may mean inflated pricing from some distributors. Compare prices across at least 2-3 distributors.

Insurance Coverage for Dental Local Anesthesia

For patients who pay a portion of their dental bill, understanding insurance coverage helps. Local anesthesia in dentistry is almost always covered as part of the associated procedure:

• Local infiltration/block anesthesia is bundled into the procedure code — not separately billable as D9930 in most plans
• Sedation (nitrous oxide D9230, IV sedation D9241) is separately billed — this is distinct from local anesthetic
• The specific local anesthetic used does not change insurance reimbursement — switching from Citanest to mepivacaine does not affect claim adjudication

Patient Assistance Resources for Dental Costs

For patients experiencing financial hardship, dental practices can provide referrals to:

• Federally Qualified Health Centers (FQHCs): Dental services on a sliding-fee scale based on income. Locate at findahealthcenter.hrsa.gov.
• State Medicaid Dental Programs: Dental coverage for adults varies by state; all states cover children's dental under CHIP/Medicaid.
• Dental school clinics: Accredited dental school clinics offer treatment at 50-70% below private practice rates under faculty supervision.
• CareCredit and LendingClub Patient Solutions: Third-party patient financing programs; CareCredit offers interest-free periods of 12-24 months for qualifying patients.
• In-house membership plans: Practice-designed plans where uninsured patients pay an annual fee for preventive care and discounts on restorative treatment. Companies like Careington, ODP, or BoomCloud provide turnkey platforms.

Communicating the Anesthetic Change Without Financial Anxiety

When notifying patients about the switch from Citanest, reassure them that:

• The alternative anesthetic is equally effective and clinically appropriate for their needs
• The change does not affect their procedure fee or insurance coverage
• Their medical needs were considered in selecting the alternative (especially important for patients who had a medical reason for Citanest Plain)

How medfinder Supports Your Practice

When any anesthetic or medication becomes difficult to source, medfinder for providers helps your team quickly confirm availability at supply sources near your practice without spending time on hold. medfinder contacts distributors and reports back which ones have your medication in stock — saving your team hours of calls and allowing you to make faster clinical decisions.

For more clinical guidance, see our Citanest shortage guide for providers.